Compare TGB & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TGB | TXG |
|---|---|---|
| Founded | 1966 | 2012 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | N/A | 2019 |
| Metric | TGB | TXG |
|---|---|---|
| Price | $5.18 | $15.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 13 |
| Target Price | $5.00 | ★ $15.35 |
| AVG Volume (30 Days) | ★ 6.2M | 2.6M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $428,559,326.00 | ★ $641,814,000.00 |
| Revenue This Year | $10.35 | $4.50 |
| Revenue Next Year | $61.39 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 0.50 | ★ 1.92 |
| 52 Week Low | $1.67 | $6.78 |
| 52 Week High | $5.57 | $20.34 |
| Indicator | TGB | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 57.42 | 44.45 |
| Support Level | $5.03 | $15.18 |
| Resistance Level | $5.57 | $18.38 |
| Average True Range (ATR) | 0.23 | 0.87 |
| MACD | -0.02 | -0.45 |
| Stochastic Oscillator | 29.46 | 14.37 |
Taseko Mines Ltd is a Canadian mining company. It is principally engaged in the production and sale of metals, as well as related activities, including exploration and mine development, within the province of British Columbia, Canada, and the State of Arizona, the United States. The Gibraltar, Aley, New Prosperity, Yellowhead properties are located in British Columbia whereas Florence copper is in central Arizona.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).